Latest News and Press Releases

InnoCare's novel BCL2i mesutoclax in MDS and AML was released at 2026 ASCO as an oral presentation, demonstrating outstanding efficacy and safety.

– 87% ORR and 70% CRc in venetoclax-naïve and 48% ORR and 24% CRc in venetoclax-experienced patients at the recommended 600 mg once-daily dose – – Central MRD negativity in 75% of CRc responders with...

The data show that mesutoclax demonstrates outstanding efficacy and safety in treating various hematologic malignancies.

Entries are now open for the inaugural Future Digital Awards for Identity & Security 2026. Apply via the entry form on the website. Entry is free.

AUSTIN, Texas, May 11, 2026 (GLOBE NEWSWIRE) -- SEON, the AI Command Center for Fraud Prevention and AML Compliance, today announced the appointment of Sagnik Nandy, Chief Technology Officer and...

TOKYO and SAN DIEGO, April 24, 2026 (GLOBE NEWSWIRE) -- Kyowa Kirin Co., Ltd. (TSE: 4151, “Kyowa Kirin”) and Kura Oncology, Inc. (Nasdaq: KURA, “Kura”) today announced the first patient has been...

Exicure enters co-development agreement with Adbiotech to advance Burixafor (GPC-100) combination therapies across multiple indications.

Facephi Strengthens Its International Expansion with the Opening of a Subsidiary in Canada The Biometric and Digital Identity sector within the Canadian financial sector is expected to maintain CAGR...

Facephi Adds New Client for Mule Account Detection and Behavioral Biometrics in Central America for 5 Years Leading financial institution with over US$14 billion in assets and more than 5 million...

As Fraud Prevention Month 2026 unfolds, Facephi, as a member of the DIACC, is contributing an expert perspective